In immune-competent mice of Her2+MMTV-Neu breast cancer and chemical-induced lung cancer, RXR agonist (MSU42011) [178] attenuated tumor growth in combination with PD1/PDL1-blocking Abs. This evidence concerns the gene CD274 and lung cancer.